These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 26879281)

  • 21. Growth at 2 Years of Age in HIV-exposed Uninfected Children in the United States by Trimester of Maternal Antiretroviral Initiation.
    Jacobson DL; Patel K; Williams PL; Geffner ME; Siberry GK; DiMeglio LA; Crain MJ; Mirza A; Chen JS; McFarland E; Kacanek D; Silio M; Rich K; Borkowsky W; Van Dyke RB; Miller TL;
    Pediatr Infect Dis J; 2017 Feb; 36(2):189-197. PubMed ID: 27798548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of human immunodeficiency virus-infected pregnant women at Latin American and Caribbean sites.
    Read JS; Cahn P; Losso M; Pinto J; Joao E; Duarte G; Cardoso E; Freimanis-Hance L; Stoszek SK;
    Obstet Gynecol; 2007 Jun; 109(6):1358-67. PubMed ID: 17540808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic complications of in utero maternal HIV and antiretroviral exposure in HIV-exposed infants.
    Jao J; Abrams EJ
    Pediatr Infect Dis J; 2014 Jul; 33(7):734-40. PubMed ID: 24378947
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Declines in low birth weight and preterm birth among infants who were born to HIV-infected women during an era of increased use of maternal antiretroviral drugs: Pediatric Spectrum of HIV Disease, 1989-2004.
    Schulte J; Dominguez K; Sukalac T; Bohannon B; Fowler MG;
    Pediatrics; 2007 Apr; 119(4):e900-6. PubMed ID: 17353299
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of adverse pregnancy outcomes in women infected with HIV in Latin America and the Caribbean: a cohort study.
    Kreitchmann R; Li SX; Melo VH; Fernandes Coelho D; Watts DH; Joao E; Coutinho CM; Alarcon JO; Siberry GK
    BJOG; 2014 Nov; 121(12):1501-8. PubMed ID: 24602102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In-utero exposure to antiretrovirals and neurodevelopment among HIV-exposed-uninfected children in Botswana.
    Chaudhury S; Mayondi GK; Williams PL; Leidner J; Shapiro R; Diseko M; Ajibola G; Holding P; Tepper V; Makhema J; Petlo C; Seage GR; Lockman S; Kammerer B
    AIDS; 2018 Jun; 32(9):1173-1183. PubMed ID: 29547434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Growth patterns of infants with in- utero HIV and ARV exposure in Cape Town, South Africa and Lusaka, Zambia.
    Nyemba DC; Kalk E; Vinikoor MJ; Madlala HP; Mubiana-Mbewe M; Mzumara M; Moore CB; Slogrove AL; Boulle A; Davies MA; Myer L; Powis K
    BMC Public Health; 2022 Jan; 22(1):55. PubMed ID: 35000577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety of in utero and neonatal antiretroviral exposure: cognitive and academic outcomes in HIV-exposed, uninfected children 5-13 years of age.
    Nozyce ML; Huo Y; Williams PL; Kapetanovic S; Hazra R; Nichols S; Hunter S; Smith R; Seage GR; Sirois PA;
    Pediatr Infect Dis J; 2014 Nov; 33(11):1128-33. PubMed ID: 25361407
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreased Mitochondrial Function Among Healthy Infants Exposed to Antiretrovirals During Gestation, Delivery and the Neonatal Period.
    Noguera-Julian A; Morén C; Rovira N; Garrabou G; Catalán M; Sánchez E; Cardellach F; Miró Ó; Fortuny C
    Pediatr Infect Dis J; 2015 Dec; 34(12):1349-54. PubMed ID: 26372453
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Infant outcomes after maternal antiretroviral exposure in resource-limited settings.
    Nielsen-Saines K; Komarow L; Cu-Uvin S; Jourdain G; Klingman KL; Shapiro DE; Mofenson L; Moran L; Campbell TB; Hitti J; Fiscus S; Currier J;
    Pediatrics; 2012 Jun; 129(6):e1525-32. PubMed ID: 22585772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of new antiretrovirals on hematological toxicity in HIV-exposed uninfected infants.
    Rovira N; Noguera-Julian A; Rives S; Berrueco R; Lahoz R; Fortuny C
    Eur J Pediatr; 2016 Jul; 175(7):1013-7. PubMed ID: 27165499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Severe Infections in HIV-Exposed Uninfected Infants Born in a European Country.
    Adler C; Haelterman E; Barlow P; Marchant A; Levy J; Goetghebuer T
    PLoS One; 2015; 10(8):e0135375. PubMed ID: 26284528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Longitudinal adherence to antiretroviral drugs for preventing mother-to-child transmission of HIV in Zambia.
    Okawa S; Chirwa M; Ishikawa N; Kapyata H; Msiska CY; Syakantu G; Miyano S; Komada K; Jimba M; Yasuoka J
    BMC Pregnancy Childbirth; 2015 Oct; 15():258. PubMed ID: 26459335
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyperlactatemia and in utero exposure to antiretrovirals: is the control group the clue?
    Soler-Palacín P; Martín-Nalda A; Martínez-Gómez X; Melendo S; Riudor E; Arranz JA; Espiau M; Figueras C
    AIDS Res Hum Retroviruses; 2012 Aug; 28(8):752-8. PubMed ID: 22010980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Leukocyte telomere length in HIV-infected pregnant women treated with antiretroviral drugs during pregnancy and their uninfected infants.
    Imam T; Jitratkosol MH; Soudeyns H; Sattha B; Gadawski I; Maan E; Forbes JC; Alimenti A; Lapointe N; Lamarre V; Money DM; Côté HC;
    J Acquir Immune Defic Syndr; 2012 Aug; 60(5):495-502. PubMed ID: 22580562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A prospective controlled study of neurodevelopment in HIV-uninfected children exposed to combination antiretroviral drugs in pregnancy.
    Alimenti A; Forbes JC; Oberlander TF; Money DM; Grunau RE; Papsdorf MP; Maan E; Cole LJ; Burdge DR
    Pediatrics; 2006 Oct; 118(4):e1139-45. PubMed ID: 16940166
    [TBL] [Abstract][Full Text] [Related]  

  • 37. First-trimester exposure to newer antiretroviral agents and congenital anomalies in a US cohort.
    Fung K; Hernandez-Diaz S; Zash R; Chadwick EG; Van Dyke RB; Broadwell C; Jao J; Powis K; Yee LM; Williams PL;
    AIDS; 2024 Sep; 38(11):1686-1695. PubMed ID: 38864586
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Prospective Cohort Study of Common Childhood Infections in South African HIV-exposed Uninfected and HIV-unexposed Infants.
    Slogrove AL; Esser MM; Cotton MF; Speert DP; Kollmann TR; Singer J; Bettinger JA
    Pediatr Infect Dis J; 2017 Feb; 36(2):e38-e44. PubMed ID: 28081048
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Higher prevalence of stunting and poor growth outcomes in HIV-exposed uninfected than HIV-unexposed infants in Kenya.
    Neary J; Langat A; Singa B; Kinuthia J; Itindi J; Nyaboe E; Ng'anga' LW; Katana A; John-Stewart GC; McGrath CJ
    AIDS; 2022 Mar; 36(4):605-610. PubMed ID: 34750290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exposure to antiretroviral agents during pregnancy does not alter bone status in infants.
    Mora S; Giacomet V; Viganò A; Cafarelli L; Stucchi S; Pivetti V; Manfredini V; Puzzovio M; Zuccotti G
    Bone; 2012 Jan; 50(1):255-8. PubMed ID: 22080170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.